Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Restore Flow Allografts
- Ownership
- Private
- Development stage
- Other
01
Overview
Restore Flow Allografts specializes in cryopreserved human vascular allografts for complex vascular reconstructions, particularly in patients lacking suitable autologous conduit tissue or at high risk of infection. Their products are used in peripheral bypass, hemodialysis access, and treatment of infected arterial grafts, with a focus on limb salvage and durable alternatives in high-risk scenarios.
- Therapeutic areas
- NephrologyCardiovascularInfectious Diseases
- Modalities
- Cryopreserved biologic tissue
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on Restore Flow Allografts.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Restore Flow Allografts.